Ashland posted a solid Q3 2026, with 7% revenue growth to $497 million and a turn to net income of $16 million. The company reaffirmed full-year guidance and returned to a net leverage of about 2.4x, underscoring improved profitability and strong cash generation. Management expects continued Q4 benefits from pricing actions and steady demand in Life Sciences and Personal Care.
In uncertain market conditions, Ashland Inc (ASH) remains a favored dividend-yielding stock. Analysts highlight ASH's strong free cash flow and favorable ratings, making it an attractive investment.
- Ashland reported Q1 revenue of $575 million, down 4.6% year-over-year. - EPS was $1.27, beating estimates by +6.72%. - Revenue for Life Sciences and Intermediates missed estimates, Personal Care beat estimates. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings